Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Surgical Science Sweden AB's Net Income (Continuing Operations) for the
three
months ended in Mar. 2026 was $2.0 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2026 was $5.7 Mil.
Surgical Science Sweden AB (OTCPK:SUSRF) Net Income (Continuing Operations) Explanation
Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.
Surgical Science Sweden AB Net Income (Continuing Operations) Related Terms
Surgical Science Sweden AB Net Income (Continuing Operations) Historical Data
* Premium members only.
The historical data trend for Surgical Science Sweden AB's Net Income (Continuing Operations) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Science Sweden AB Net Income (Continuing Operations) Chart
Surgical Science Sweden AB Net Income (Continuing Operations) Calculation
Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.
Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Income (Continuing Operations) of $5.7 Mil mean?
Surgical Science Sweden AB (SUSRF) has a Net Income (Continuing Operations) of $5.7 Mil as of Mar. 2026. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Surgical Science Sweden AB and its competitors.
Is Surgical Science Sweden AB's Net Income (Continuing Operations) too high?
Surgical Science Sweden AB's current Net Income (Continuing Operations) is $5.7 Mil. Overall, Surgical Science Sweden AB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Net Income (Continuing Operations) compare to VEEV and BTSG?
Surgical Science Sweden AB's Net Income (Continuing Operations) of $5.7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Healthcare Providers & Services company?
A good Net Income (Continuing Operations) depends on the Healthcare Providers & Services industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current Net Income (Continuing Operations) is $5.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Surgical Science Sweden AB (SUSRF) has a current Net Income (Continuing Operations) of $5.7 Mil. The stock's GF Value™ is $15.91, compared to a current price of $4.00 — trading 74.9% below its estimated fair value. The current Net Income (Continuing Operations) is $5.7 Mil. Surgical Science Sweden AB's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Net Income (Continuing Operations) is $5.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of $4.00 is trading 74.9% below its estimated GF Value™ of $15.91.
Key valuation signals for SUSRF:
Net Income (Continuing Operations): $5.7 Mil
GF Value™: $15.91 vs. price of $4.00 (74.9% below fair value)
No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
85GF Score
Get the complete analysis for SUSRF
Net Income (Continuing Operations) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SUSRF has been successfully added to your 
